Loading company…
ID 445396884 · FY 2018–2024 · 7 years
მისი ძირითადი საქმიანობაა ინტერვენციული კარდიოლოგიური სახარჯი მასალების რეალიზაცია.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,832 | 4,174 | 3,494 | 6,882 | 5,575 | 6,236 | 6,924 | +10.4% |
| Total COGS | -2,543 | -2,746 | -2,444 | -5,346 | -3,843 | -4,040 | -4,516 | +10.0% |
| Gross Profit | 1,289 | 1,427 | 1,050 | 1,536 | 1,732 | 2,196 | 2,408 | +11.0% |
| Gross Margin | 33.6% | 34.2% | 30.0% | 22.3% | 31.1% | 35.2% | 34.8% | |
| Total Operating Expenses | -194 | -194 | -179 | -181 | -244 | -287 | -247 | +4.1% |
| EBITDA | 1,094 | 1,233 | 871 | 1,355 | 1,487 | 1,909 | 2,161 | +12.0% |
| EBITDA Margin | 28.6% | 29.5% | 24.9% | 19.7% | 26.7% | 30.6% | 31.2% | |
| Total D&A | -9 | -8 | -7 | -9 | -6 | -10 | -10 | +2.1% |
| EBIT / Operating Income | 1,086 | 1,225 | 864 | 1,346 | 1,482 | 1,899 | 2,151 | +12.1% |
| Total Interest Income | 0 | 0 | 0 | 0 | 0 | 35 | 70 | +100.6% |
| Total Interest Expense | 0 | 0 | 0 | -3 | 0 | 0 | -15 | +68.4% |
| Total Other Income | -59 | -78 | -21 | -33 | -18 | -13 | -37 | -7.6% |
| Profit Before Tax | 1,027 | 1,147 | 843 | 1,309 | 1,464 | 1,921 | 2,170 | +13.3% |
| Total Income Tax | -1 | -81 | -43 | -78 | -61 | -85 | -89 | +99.6% |
| Net Profit / (Loss) | 1,033 | 1,074 | 796 | 1,234 | 1,405 | 1,810 | 2,035 | +12.0% |
| Net Margin | 26.9% | 25.7% | 22.8% | 17.9% | 25.2% | 29.0% | 29.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sector, ranked by how close their latest revenue is to this one — not a curated comp set.